Home Calendar Movers Compare
S&P 500 680.29 -0.89% Nasdaq 601.58 -1.07% Dow 30 485.51 -0.75% Apple 264.72 +0.20% Nvidia 191.55 +0.91% Tesla 403.32 +0.20%
Pre-Market | 300 companies reporting this week
Home / Calendar / RPRX

RPRX

Royalty Pharma plc - Class A
BIOTECHNOLOGY · HEALTHCARE
Royalty Pharma Plc, headquartered in New York, is a leading entity in the biopharmaceutical royalty acquisition arena, specializing in the acquisition of royalties from established market drugs and promising development pipelines. The company's strategic focus on funding innovative therapies not onl...
$47.47
90-day price trend
+2.73% (+$1.26)
Volume 4.41M
52W High $47.66
52W Low $29.66
Market Cap $25.78B
← Back to Calendar Compare with Others →

What to Watch This Quarter

Based on historical data
Consensus EPS
$1.10
Whisper EPS
$1.18
7.2% above consensus
Last Quarter
$1.47
Current Streak
6 Beats
Avg Surprise (4Q)
+11.32%

Next Earnings Report

Reports in 63 days
Report Date May 7, 2026
Whisper Spread +7.15%
Consensus Estimate
$1.10
Official analyst average
Whisper Number
$1.18
What traders expect
Bullish Sentiment: The whisper number is 7.2% above consensus, suggesting traders expect a strong beat. The stock may be priced for upside surprise.

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q4 2025 Feb 11, 2026
1-Day: +1.24%
Q3 2025 Nov 5, 2025
1-Day: +0.89%
5-Day: -4.65%
Q2 2025 Aug 6, 2025
1-Day: -0.30%
5-Day: -2.51%
Q1 2025 May 8, 2025
1-Day: +0.15%
5-Day: -0.85%

Revenue & Financial Performance

Revenue Whisper
$610.0M
TWN Proprietary Estimate
Last Quarter Revenue
$622.0M
+4.8% YoY
Gross Margin
100.0%
Net Margin: 34.4%
Quarter Revenue YoY Growth Gross Margin Op Margin Net Income
Q4'25 $622.0M +4.8% 100.0% 62.4% $214.2M
Q3'25 $609.3M +7.9% 100.0% 70.1% $288.2M
Q2'25 $578.7M +7.7% 100.0% 36.3% $30.2M
Q1'25 $568.2M +0.1% 100.0% 94.0% $238.3M
Q4'24 $593.6M -0.4% 100.0% 60.9% $208.2M
Q3'24 $564.7M +5.3% 100.0% 130.2% $544.0M
Q2'24 $537.3M -0.2% 100.0% 50.2% $102.0M
Q1'24 $568.0M -17.0% 100.0% -13.0% $4.8M

Historical Earnings

Last 12 quarters
Quarter Date Consensus Whisper Actual EPS Surprise % Result
Q4 2025 Feb 11, 2026 $1.33 $1.47 $1.47 +10.53% Met
Q3 2025 Nov 5, 2025 $1.04 $1.12 $1.17 +12.50% Beat
Q2 2025 Aug 6, 2025 $1.03 $1.09 $1.14 +10.68% Beat
Q1 2025 May 8, 2025 $0.95 $0.99 $1.06 +11.58% Beat
Q4 2024 Feb 11, 2025 $1.05 $0.26 $1.15 +9.52% Beat
Q3 2024 Nov 6, 2024 $0.93 $1.00 $1.04 +11.83% Beat
Q2 2024 Aug 8, 2024 $0.97 $1.04 $0.96 -1.03% Missed
Q1 2024 May 9, 2024 $0.98 $1.08 $0.98 +0.00% Missed
Q4 2023 Feb 15, 2024 $1.00 $1.06 $1.52 +52.00% Beat
Q3 2023 Nov 8, 2023 $0.77 $0.82 $0.79 +2.60% Missed
Q2 2023 Aug 8, 2023 $0.81 $0.86 $0.84 +3.70% Missed
Q1 2023 May 9, 2023 $1.27 $1.30 $1.60 +25.98% Beat

Company Information

Symbol
RPRX
Company
Royalty Pharma plc - Class A
Market Cap
$25.78B
Sector
HEALTHCARE
Next Earnings
May 7, 2026
include __DIR__ . '/includes/footer.php'; ?>